Layoffs and restructuring will prepare Leo Pharma for IPO

On Wednesday, Leo Pharma has let go of 68 employees, and a total of 1,000 positions in the organization will be affected over the next two years. The new operating model is meant to raise earnings prior to an initial public offering, the company says.

Photo: Leo Pharma / PR

The fact that Leo Pharma is currently without a permanent CEO hasn’t changed the company’s great plans for the future.

On Wednesday, Leo Pharma announces that it is letting go of 68 employees as a part of changes to the global organization to support its 2030 strategy, in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs